Crispr Therapeutics shares owned by Envestnet Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Envestnet Asset Management
from 13F filings
Historical chart of Envestnet Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Envestnet Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $1.3M | 29k | 45.39 |
| 2023-06-30 | $1.0M | 18k | 56.14 |
| 2023-03-31 | $884k | 20k | 45.23 |
| 2022-12-31 | $995k | 25k | 40.65 |
| 2022-09-30 | $1.4M | 22k | 65.33 |
| 2022-06-30 | $1.3M | 22k | 60.75 |
| 2022-03-31 | $1.2M | 19k | 62.76 |
| 2021-12-31 | $1.2M | 16k | 75.76 |
| 2021-09-30 | $1.8M | 16k | 111.95 |
| 2021-06-30 | $3.5M | 22k | 161.87 |
| 2021-03-31 | $1.9M | 16k | 121.87 |
| 2020-12-31 | $1.5M | 9.5k | 153.09 |
| 2020-09-30 | $337k | 4.0k | 83.71 |
More positions owned by Envestnet Asset Management
View all positions for Envestnet Asset Management